Acitretin is an oral synthetic retinoid effective in the treatment of psori
asis. As monotherapy!: acitretin has been shown to be most effective in tre
ating pustular and erythrodermic types of the disease. Monotherapy with aci
tretin for plaque-type psoriasis is often less successful; however, its use
in combination with other therapies is highly effective in treating this f
orm of the disease, Dose-response studies have established the effective do
se range of acitretin as well as the dose-dependence of its side effects. B
ecause both efficacy and side effects can vary substantially among individu
al patients, proper dosing of acitretin requires a balance between optimizi
ng response and minimizing toxicity for each patient. Optimal dosing for in
dividual patients may be achieved through a dose-escalation strategy involv
ing initiation of therapy at low doses (10 to 25 mg/day) and, if necessary,
gradually increasing the dose as tolerated until optimal response is achie
ved.